Bioventus announced that it will now report financial results for the fourth quarter of fiscal year 2022 before the market opens on Friday, March 31, 2023, rather than as previously announced to allow additional time to complete its financial statements. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BVS:
- Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
- Bioventus, Inc. (BVS) Q4 Earnings Cheat Sheet
- Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
- Bioventus enters settlement agreement with former CartiHeal shareholders
- Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition